Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Crosstalk between bile acid-activated receptors and microbiome in entero-hepatic inflammation
Morgane M. Thibaut, Laure B. Bindels
Trends in Molecular Medicine (2022) Vol. 28, Iss. 3, pp. 223-236
Closed Access | Times Cited: 97

Showing 1-25 of 97 citing articles:

Bile acids and the gut microbiota: metabolic interactions and impacts on disease
Stephanie L. Collins, Jonathan G. Stine, Jordan E. Bisanz, et al.
Nature Reviews Microbiology (2022) Vol. 21, Iss. 4, pp. 236-247
Closed Access | Times Cited: 455
Gut liver brain axis in diseases: the implications for therapeutic interventions
Mengyao Yan, Shuli Man, Benyue Sun, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 73
Another renaissance for bile acid gastrointestinal microbiology
Jason M. Ridlon, H. Rex Gaskins
Nature Reviews Gastroenterology & Hepatology (2024) Vol. 21, Iss. 5, pp. 348-364
Closed Access | Times Cited: 45
Dietary fiber alleviates alcoholic liver injury via Bacteroides acidifaciens and subsequent ammonia detoxification
Haiyuan Shen, Liangliang Zhou, Hao Zhang, et al.
Cell Host & Microbe (2024) Vol. 32, Iss. 8, pp. 1331-1346.e6
Closed Access | Times Cited: 18
Gut-liver axis: Pathophysiological concepts and medical perspective in chronic liver diseases
Susana Rodrigues, Van der Merwe, Aleksander Krag, et al.
Seminars in Immunology (2024) Vol. 71, pp. 101859-101859
Open Access | Times Cited: 15
Bifidobacterium longum promotes postoperative liver function recovery in patients with hepatocellular carcinoma
Jingjing Yu, Peng Zhu, Linlin Shi, et al.
Cell Host & Microbe (2023) Vol. 32, Iss. 1, pp. 131-144.e6
Open Access | Times Cited: 28
The roles of gut microbiota and its metabolites in diabetic nephropathy
Hui Zhao, Cheng-E Yang, Tian Liu, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 24
Bile acid and short chain fatty acid metabolism of gut microbiota mediate high-fat diet induced intestinal barrier damage in Macrobrachium rosenbergii
Xiaochuan Zheng, Xiaodi Xu, Mingyang Liu, et al.
Fish & Shellfish Immunology (2024) Vol. 146, pp. 109376-109376
Closed Access | Times Cited: 13
Two intestinal microbiota-derived metabolites, deoxycholic acid and butyrate, synergize to enhance host defense peptide synthesis and alleviate necrotic enteritis
Do-Hyung Kim, Jing Liu, Melanie A. Whitmore, et al.
Journal of Animal Science and Biotechnology/Journal of animal science and biotechnology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 13
Role of the intestinal microbiota in contributing to weight disorders and associated comorbidities
Matthias Van Hul, Audrey M. Neyrinck, Amandine Everard, et al.
Clinical Microbiology Reviews (2024) Vol. 37, Iss. 3
Closed Access | Times Cited: 13
Novel approaches in IBD therapy: targeting the gut microbiota-bile acid axis
Yinping Pan, Haojie Zhang, Minghui Li, et al.
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 10
Psoriasis: Interplay between dysbiosis and host immune system
Bhupinder Kapoor, Monica Gulati, Pooja Rani, et al.
Autoimmunity Reviews (2022) Vol. 21, Iss. 11, pp. 103169-103169
Closed Access | Times Cited: 34
Bifidobacterium longum CECT 7894 Improves the Efficacy of Infliximab for DSS-Induced Colitis via Regulating the Gut Microbiota and Bile Acid Metabolism
Fangfei Xiao, Fang Dong, Xiaolu Li, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 32
The interaction of bile acids and gut inflammation influences the pathogenesis of inflammatory bowel disease
Agostino Di Ciaula, Leonilde Bonfrate, Mohamad Khalil, et al.
Internal and Emergency Medicine (2023) Vol. 18, Iss. 8, pp. 2181-2197
Open Access | Times Cited: 19
Neuroinflammation and Neurodegenerative Diseases: How Much Do We Still Not Know?
Carmela Rita Balistreri, Roberto Monastero
Brain Sciences (2023) Vol. 14, Iss. 1, pp. 19-19
Open Access | Times Cited: 19
Gut-muscle axis and sepsis-induced myopathy: The potential role of gut microbiota
Yukun Liu, Ligang Xu, Zhaohui Yang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 163, pp. 114837-114837
Open Access | Times Cited: 17
Sedanolide alleviates DSS-induced colitis by modulating the intestinal FXR-SMPD3 pathway in mice
Shengjie Li, Aoxiang Zhuge, Hui Chen, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 5
The microbiota-derived bile acid taurodeoxycholic acid improves hepatic cholesterol levels in mice with cancer cachexia
Morgane M. Thibaut, Martin Roumain, Edwige Piron, et al.
Gut Microbes (2025) Vol. 17, Iss. 1
Open Access
Gut microbiota: a new insight into neurological diseases
Lanxiang Liu, Haiyang Wang, Xueyi Chen, et al.
Chinese Medical Journal (2022) Vol. 136, Iss. 11, pp. 1261-1277
Open Access | Times Cited: 23
The regulation of tissue-specific farnesoid X receptor on genes and diseases involved in bile acid homeostasis
Dong Xiang, Jinyu Yang, Lu Liu, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115606-115606
Open Access | Times Cited: 15
Gut microbiota-derived 12-ketolithocholic acid suppresses the IL-17A secretion from colonic group 3 innate lymphoid cells to prevent the acute exacerbation of ulcerative colitis
Na Li, Pei-guang Ma, Yalan Li, et al.
Gut Microbes (2023) Vol. 15, Iss. 2
Open Access | Times Cited: 14
Role of Microbiota-Modified Bile Acids in the Regulation of Intracellular Organelles and Neurodegenerative Diseases
Yoshimitsu Kiriyama, Hiromi Nochi
Genes (2023) Vol. 14, Iss. 4, pp. 825-825
Open Access | Times Cited: 12
Crosstalk between Gut Microbiota and Bile Acids in Cholestatic Liver Disease
Qingmiao Shi, Xin Yuan, Yifan Zeng, et al.
Nutrients (2023) Vol. 15, Iss. 10, pp. 2411-2411
Open Access | Times Cited: 12
Bile acids, gut microbiota, and therapeutic insights in hepatocellular carcinoma
Yang Song, Harry Cheuk-Hay Lau, Xiang Zhang, et al.
Cancer Biology and Medicine (2023), pp. 1-19
Open Access | Times Cited: 12
Diosgenin as a substitute for cholesterol alleviates NAFLD by affecting CYP7A1 and NPC1L1-related pathway
Mengyao Yan, Yixin Zhao, Shuli Man, et al.
Phytomedicine (2024) Vol. 125, pp. 155299-155299
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top